{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:08:23Z","timestamp":1793113703669,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["GS-10F-0133S"],"award-info":[{"award-number":["GS-10F-0133S"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11606-024-09208-5","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T12:30:13Z","timestamp":1732537813000},"page":"587-594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antipsychotics and Risk of Acute Respiratory Failure in U.S. Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1272-1502","authenticated-orcid":false,"given":"Silvia","family":"Perez-Vilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Mosholder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Chi","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Brehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armen","family":"Avagyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira","family":"Leishear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wernecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"MaCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Kelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"9208_CR1","doi-asserted-by":"publisher","unstructured":"Taylor LG, Panucci G, Mosholder AD, Toh S, Huang TY. Antipsychotic Use and Stroke: A Retrospective Comparative Study in a Non-Elderly Population. J Clin Psychiatry. Jun 4 2019;80(4). https:\/\/doi.org\/10.4088\/JCP.18m12636","DOI":"10.4088\/JCP.18m12636"},{"issue":"3","key":"9208_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1001\/jamapsychiatry.2016.3793","volume":"74","author":"MT Wang","year":"2017","unstructured":"Wang MT, Tsai CL, Lin CW, Yeh CB, Wang YH, Lin HL. Association Between Antipsychotic Agents and Risk of Acute Respiratory Failure in Patients With Chronic Obstructive Pulmonary Disease. JAMA Psychiatry. Mar 1 2017;74(3):252-260. https:\/\/doi.org\/10.1001\/jamapsychiatry.2016.3793","journal-title":"JAMA Psychiatry."},{"key":"9208_CR3","doi-asserted-by":"publisher","unstructured":"Wang MT, Lin CW, Tsai CL, et al. Use of antipsychotics and the risk of acute respiratory failure among adults: A disease risk score-matched nested case-control study. Br J Clin Pharmacol. Apr 26 2020; https:\/\/doi.org\/10.1111\/bcp.14321","DOI":"10.1111\/bcp.14321"},{"issue":"5","key":"9208_CR4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/s0735-6757(98)90001-8","volume":"16","author":"AA Acri","year":"1998","unstructured":"Acri AA, Henretig FM. Effects of risperidone in overdose. Am J Emerg Med. Sep 1998;16(5):498-501. https:\/\/doi.org\/10.1016\/s0735-6757(98)90001-8","journal-title":"Am J Emerg Med."},{"issue":"5","key":"9208_CR5","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1213\/01.ANE.0000180195.57760.E9","volume":"101","author":"A Akyol","year":"2005","unstructured":"Akyol A, Senel AC, Ulusoy H, Karip F, Erciyes N. Delayed respiratory depression after risperidone overdose. Anesth Analg. Nov 2005;101(5):1490-1. https:\/\/doi.org\/10.1213\/01.ANE.0000180195.57760.E9","journal-title":"Anesth Analg."},{"issue":"3","key":"9208_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-2008-1058111","volume":"41","author":"RW Freudenmann","year":"2008","unstructured":"Freudenmann RW, Sussmuth SD, Wolf RC, Stiller P, Schonfeldt-Lecuona C. Respiratory dysfunction in sleep apnea associated with quetiapine. Pharmacopsychiatry. May 2008;41(3):119-21. https:\/\/doi.org\/10.1055\/s-2008-1058111","journal-title":"Pharmacopsychiatry."},{"issue":"3","key":"9208_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1345\/aph.1G495","volume":"40","author":"S Jabeen","year":"2006","unstructured":"Jabeen S, Polli SI, Gerber DR. Acute respiratory failure with a single dose of quetiapine fumarate. Ann Pharmacother. Mar 2006;40(3):559-62. https:\/\/doi.org\/10.1345\/aph.1G495","journal-title":"Ann Pharmacother."},{"issue":"4","key":"9208_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00007611-198804000-00038","volume":"81","author":"MD Johnson","year":"1988","unstructured":"Johnson MD, Newman JH, Baxter JW. Neuroleptic malignant syndrome presenting as adult respiratory distress syndrome and disseminated intravascular coagulation. South Med J. Apr 1988;81(4):543-5. https:\/\/doi.org\/10.1097\/00007611-198804000-00038","journal-title":"South Med J."},{"issue":"3","key":"9208_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/00019442-200108000-00016","volume":"9","author":"M Mouallem","year":"2001","unstructured":"Mouallem M, Wolf I. Olanzapine-induced respiratory failure. Am J Geriatr Psychiatry. Summer 2001;9(3):304-5.","journal-title":"Am J Geriatr Psychiatry. Summer"},{"issue":"2","key":"9208_CR10","first-page":"103","volume":"59","author":"DF Peek","year":"2008","unstructured":"Peek DF. A patient with haloperidol induced laryngeal dystonia. Acta Anaesthesiol Belg. 2008;59(2):103-5.","journal-title":"Acta Anaesthesiol Belg."},{"issue":"3","key":"9208_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1590\/s1516-31802003000300007","volume":"121","author":"FG Soriano","year":"2003","unstructured":"Soriano FG, Vianna Edos S, Velasco IT. Neuroleptic-induced acute respiratory distress syndrome. Sao Paulo Med J. May 5 2003;121(3):121-4. https:\/\/doi.org\/10.1590\/s1516-31802003000300007","journal-title":"Sao Paulo Med J."},{"issue":"4","key":"9208_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1592\/phco.26.4.578","volume":"26","author":"PM Strachan","year":"2006","unstructured":"Strachan PM, Benoff BA. Mental status change, myoclonus, electrocardiographic changes, and acute respiratory distress syndrome induced by quetiapine overdose. Pharmacotherapy. Apr 2006;26(4):578-82. https:\/\/doi.org\/10.1592\/phco.26.4.578","journal-title":"Pharmacotherapy."},{"issue":"2","key":"9208_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/bja\/aem195","volume":"99","author":"H Wilson","year":"2007","unstructured":"Wilson H, Ridley S. Antipsychotic drugs and the acute respiratory distress syndrome. Br J Anaesth. Aug 2007;99(2):301-2. https:\/\/doi.org\/10.1093\/bja\/aem195","journal-title":"Br J Anaesth."},{"issue":"3","key":"9208_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1055\/s-0029-1242822","volume":"43","author":"F Yagmur","year":"2010","unstructured":"Yagmur F, Ulusoy HB, Buyukoglan H, Kaya MG. Acute respiratory distress due to antipsychotic drugs. Pharmacopsychiatry. May 2010;43(3):118-9. https:\/\/doi.org\/10.1055\/s-0029-1242822","journal-title":"Pharmacopsychiatry."},{"issue":"4","key":"9208_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2478\/jccm-2020-0035","volume":"6","author":"P Chia","year":"2020","unstructured":"Chia P, Chuan Poh L, Ong J, Ong S. Cardiopulmonary Arrest Following a Single 25 Mg Dose of Quetiapine: A Case Report. Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures). Oct 2020;6(4):253-258. https:\/\/doi.org\/10.2478\/jccm-2020-0035","journal-title":"Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures)"},{"key":"9208_CR16","doi-asserted-by":"publisher","unstructured":"Miranda M, M\u00e9ndez F, Renner A. [Acute upper respiratory obstruction induced by neuroleptics]. Revista medica de Chile. Jul 2010;138(7):924\u20135. Obstrucci\u00f3n respiratoria alta aguda inducida por neurol\u00e9pticos. https:\/\/doi.org\/10.4067\/s0034-98872010000700022","DOI":"10.4067\/s0034-98872010000700022"},{"issue":"S2","key":"9208_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.5518","volume":"31","author":"O Illoh","year":"2022","unstructured":"Illoh O, DosReis S. Use of antipsychotics and the risk of acute respiratory failure. Abstract #138. Pharmacoepidemiol Drug Saf. 2022;31(S2):3-628.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"9208_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/oxfordjournals.aje.a115853","volume":"133","author":"M Maclure","year":"1991","unstructured":"Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. Jan 15 1991;133(2):144-53. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a115853","journal-title":"Am J Epidemiol."},{"key":"9208_CR19","unstructured":"CMS. Medicare Program - General Information. Accessed September 19, 2022, https:\/\/www.cms.gov\/Medicare\/Medicare-General-Information\/MedicareGenInfo\/index"},{"issue":"4","key":"9208_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/pds.3548","volume":"23","author":"DJ Graham","year":"2014","unstructured":"Graham DJ, Zhou EH, McKean S, et al. Cardiovascular and mortality risk in elderly Medicare beneficiaries treated with olmesartan versus other angiotensin receptor blockers. Pharmacoepidemiol Drug Saf. Apr 2014;23(4):331-9. https:\/\/doi.org\/10.1002\/pds.3548","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"2","key":"9208_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4104\/pcrj.2009.00072","volume":"19","author":"D Mapel","year":"2010","unstructured":"Mapel D, Schum M, Yood M, Brown J, Miller D, Davis K. Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators. Prim Care Respir J. Jun 2010;19(2):109-17. https:\/\/doi.org\/10.4104\/pcrj.2009.00072","journal-title":"Prim Care Respir J."},{"key":"9208_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1472-6963-11-43","volume":"11","author":"DW Mapel","year":"2011","unstructured":"Mapel DW, Dutro MP, Marton JP, Woodruff K, Make B. Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data. BMC Health Serv Res. Feb 23 2011;11:43. https:\/\/doi.org\/10.1186\/1472-6963-11-43","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"9208_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.amjopharm.2010.10.002","volume":"8","author":"BC Stuart","year":"2010","unstructured":"Stuart BC, Simoni-Wastila L, Zuckerman IH, et al. Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary disease. Am J Geriatr Pharmacother. Oct 2010;8(5):441-53. https:\/\/doi.org\/10.1016\/j.amjopharm.2010.10.002","journal-title":"Am J Geriatr Pharmacother."},{"key":"9208_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5888\/pcd14.160333","volume":"14","author":"G Westney","year":"2017","unstructured":"Westney G, Foreman MG, Xu J, Henriques King M, Flenaugh E, Rust G. Impact of Comorbidities Among Medicaid Enrollees With Chronic Obstructive Pulmonary Disease, United States, 2009. Prev Chronic Dis. Apr 13 2017;14:E31. https:\/\/doi.org\/10.5888\/pcd14.160333","journal-title":"Prev Chronic Dis."},{"issue":"5","key":"9208_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis."},{"issue":"6","key":"9208_CR26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/aje\/kwx257","volume":"186","author":"JB Segal","year":"2017","unstructured":"Segal JB, Huang J, Roth DL, Varadhan R. External validation of the claims-based frailty index in the national health and aging trends study cohort. Am J Epidemiol. Sep 15 2017;186(6):745-747. https:\/\/doi.org\/10.1093\/aje\/kwx257","journal-title":"Am J Epidemiol."},{"issue":"1","key":"9208_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/0962280208092346","volume":"18","author":"JA Delaney","year":"2009","unstructured":"Delaney JA, Suissa S. The case-crossover study design in pharmacoepidemiology. Stat Methods Med Res. Feb 2009;18(1):53-65. https:\/\/doi.org\/10.1177\/0962280208092346","journal-title":"Stat Methods Med Res."},{"issue":"4","key":"9208_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/m16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity Analysis in Observational Research: Introducing the E-Value. Annals of internal medicine. Aug 15 2017;167(4):268-274. https:\/\/doi.org\/10.7326\/m16-2607","journal-title":"Annals of internal medicine."},{"issue":"10","key":"9208_CR29","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/aje\/kww079","volume":"184","author":"J Hallas","year":"2016","unstructured":"Hallas J, Pottegard A, Wang S, Schneeweiss S, Gagne JJ. Persistent User Bias in Case-Crossover Studies in Pharmacoepidemiology. Am J Epidemiol. Nov 15 2016;184(10):761-769. https:\/\/doi.org\/10.1093\/aje\/kww079","journal-title":"Am J Epidemiol."},{"issue":"Suppl 1","key":"9208_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/pds.2330","volume":"21","author":"M Maclure","year":"2012","unstructured":"Maclure M, Fireman B, Nelson JC, et al. When should case-only designs be used for safety monitoring of medical products? Pharmacoepidemiol Drug Saf. Jan 2012;21 Suppl 1:50-61. https:\/\/doi.org\/10.1002\/pds.2330","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"15","key":"9208_CR31","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","volume":"294","author":"LS Schneider","year":"2005","unstructured":"Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. Oct 19 2005;294(15):1934-43. https:\/\/doi.org\/10.1001\/jama.294.15.1934","journal-title":"JAMA."},{"issue":"Suppl 3","key":"9208_CR32","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1002\/(SICI)1099-1557(199710)6:3+<S51::AID-PDS301>3.0.CO;2-S","volume":"6","author":"S Schneeweiss","year":"1997","unstructured":"Schneeweiss S, Sturmer T, Maclure M. Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. Oct 1997;6 Suppl 3:S51-9. https:\/\/doi.org\/10.1002\/(SICI)1099-1557(199710)6:3+<S51::AID-PDS301>3.0.CO;2-S","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"3","key":"9208_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/00001648-199505000-00010","volume":"6","author":"S Suissa","year":"1995","unstructured":"Suissa S. The case-time-control design. Epidemiology. May 1995;6(3):248-53. https:\/\/doi.org\/10.1097\/00001648-199505000-00010","journal-title":"Epidemiology."},{"issue":"4","key":"9208_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/00001648-199807000-00016","volume":"9","author":"S Suissa","year":"1998","unstructured":"Suissa S. The case-time-control design: further assumptions and conditions. Epidemiology. Jul 1998;9(4):441-5.","journal-title":"Epidemiology."},{"issue":"4","key":"9208_CR35","doi-asserted-by":"publisher","first-page":"e203630","DOI":"10.1001\/jamanetworkopen.2020.3630","volume":"3","author":"A Rubino","year":"2020","unstructured":"Rubino A, Sanon M, Ganz ML, et al. Association of the US Food and Drug Administration Antipsychotic Drug Boxed Warning With Medication Use and Health Outcomes in Elderly Patients With Dementia. JAMA Netw Open. Apr 1 2020;3(4):e203630. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.3630","journal-title":"JAMA Netw Open."},{"issue":"5","key":"9208_CR36","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/jamainternmed.2018.0379","volume":"178","author":"DT Maust","year":"2018","unstructured":"Maust DT, Kim HM, Chiang C, Kales HC. Association of the Centers for Medicare & Medicaid Services' National Partnership to Improve Dementia Care With the Use of Antipsychotics and Other Psychotropics in Long-term Care in the United States From 2009 to 2014. JAMA Intern Med. May 1 2018;178(5):640-647. https:\/\/doi.org\/10.1001\/jamainternmed.2018.0379","journal-title":"JAMA Intern Med."},{"issue":"2","key":"9208_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1001\/jama.2017.7032","volume":"318","author":"JH Gurwitz","year":"2017","unstructured":"Gurwitz JH, Bonner A, Berwick DM. Reducing Excessive Use of Antipsychotic Agents in Nursing Homes. JAMA. Jul 11 2017;318(2):118-119. https:\/\/doi.org\/10.1001\/jama.2017.7032","journal-title":"JAMA."},{"issue":"1","key":"9208_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1001\/archinternmed.2009.456","volume":"170","author":"ER Dorsey","year":"2010","unstructured":"Dorsey ER, Rabbani A, Gallagher SA, Conti RM, Alexander GC. Impact of FDA black box advisory on antipsychotic medication use. Arch Intern Med. Jan 11 2010;170(1):96-103. https:\/\/doi.org\/10.1001\/archinternmed.2009.456","journal-title":"Arch Intern Med."},{"issue":"12","key":"9208_CR39","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1001\/jamainternmed.2014.5430","volume":"174","author":"PK Lindenauer","year":"2014","unstructured":"Lindenauer PK, Stefan MS, Shieh MS, Pekow PS, Rothberg MB, Hill NS. Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease. JAMA Intern Med. Dec 2014;174(12):1982-93. https:\/\/doi.org\/10.1001\/jamainternmed.2014.5430","journal-title":"JAMA Intern Med."},{"key":"9208_CR40","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2022 Report. 2022. Accessed September 19, 2022. https:\/\/goldcopd.org\/2022-gold-reports-2\/"},{"key":"9208_CR41","doi-asserted-by":"publisher","first-page":"204512531985996","DOI":"10.1177\/2045125319859969","volume":"9","author":"H Quigley","year":"2019","unstructured":"Quigley H, MacCabe JH. The relationship between nicotine and psychosis. Ther Adv Psychopharmacol. 2019;9:2045125319859969. https:\/\/doi.org\/10.1177\/2045125319859969","journal-title":"Ther Adv Psychopharmacol."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-09208-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-024-09208-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-09208-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:13:56Z","timestamp":1764267236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-024-09208-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["9208"],"URL":"https:\/\/doi.org\/10.1007\/s11606-024-09208-5","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"The U.S. Food and Drug Administration funded this study through an interagency agreement with the Centers for Medicare & Medicaid Services (Contract number: GS-10F-0133S).\u00a0The authors who were employees or contractors of the U.S. Food and Drug Administration and the Centers for Medicare & Medicaid Services played a role in the design; however, other officials at the U.S. Food and Drug Administration and the Centers for Medicare & Medicaid Services had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial Support:"}},{"value":"Amy Brehm\u2019s spouse owns stocks in Bristol Myers, Abbvie, and Johnson & Johnson. All other authors have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"Preliminary results of this work were presented at CHEST Annual Meeting 2022, October 16\u201319, 2022, Nashville, TN, USA.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Previous Presentation:"}},{"value":"The manuscript was subject to administrative review before submission, but this review did not alter its content. The views expressed are those of the authors and not necessarily those of the Department of Health and Human Services, the U.S. Food and Drug Administration, or the Centers for Medicare & Medicaid Services.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}